Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$50,000.00
Sep 1, 2025
For-profit organization
MDAP 2025 – Market Diversification Action Plan
1034157
The firm is targeting early adopter customers who value modernized treatment solutions, prefer Western/European medical devices, and are open to piloting the firm's products in clinical settings. Vietnam (Hanoi) is the firm's first choice due to strong ties with the national hospital network, their familiarity with oncology QA devices, and growing demand for advanced patient positioning.
$344,000.00
Sep 1, 2025
For-profit organization
AI-based prognosis for breast cancer
1034479
The use of automated prognostic imaging biomarkers in clinical practice may enhance (re-) staging and response assessment, as it could inform more personalized treatment selection and patient monitoring, which in turn could lead to improved patient outcomes.
$350,000.00
Sep 1, 2025
For-profit organization
Development of in-house scientific molding capabilities for microfluidic consumables
1034629
In-house capability to produce two integrated microfluidic discs (Clinical Chemistry, Immunoassay) that meet required specifications and reproducibility.
$30,000.00
Sep 1, 2025
For-profit organization
YOUTH - Preclinical Evaluation of an mRNA-LNP Delivered SMYD3 Peptide Therapeutic in a Small Cell Lung Cancer Model
1034846
Pre-clinical proof-of-concept studies to assess therapeutic activity in an mRNA-LNP Delivered SMYD3 Peptide Therapeutic both patient-derived cell lines and a murine xenograft model of SCLC.
$90,000.00
Sep 1, 2025
For-profit organization
AI Assist: Voice-Enabled Health Assistant for Clinical Automation
1034894
AI Health Assistant pilot
$75,000.00
Sep 1, 2025
For-profit organization
IncluzIT MVP: Technical Discovery and Development Capacity Building for Clinical Pilot Readiness
1034934
The work will also build in-house technical capacity to support ongoing product evolution and ensure platform readiness for clinical pilot testing.
$5,000.00
Sep 1, 2025
For-profit organization
Canadian Life Sciences co-innovation mission to Japan – October 2025
1037489
BioAro’s proprietary AI-driven analytics platform, PanOmiQ, processes this high-dimensional multi-OMICS data for actionable clinical output. These have helped commercialize the BioSport (high performance athletes), BioMYND (mental health) & Biogut (gut wellness & nutrition) programs. BioAro is currently focusing on Drug Development & Discovery, Drug Repurposing & Pharmacogenomics, including in-silico drug design & simulation of clinical trials. BioAro has also built a high performance computing centre
$157,000.00
Sep 1, 2025
Academia
Phage Susceptibility Testing (PST) with Microfluidics
1036567
There are no specific clinical criteria for bacteriophage susceptibility and testing with routine methods is cumbersome and manual.
$84,634.00
Sep 1, 2025
For-profit organization
Adaptation of Momentum Spine to the Adult Population.
1036938
The project aims to enhance and adapt the current version of the firm's app to fit the clinical needs of adult spine deformities, resulting in a significant expansion of addressable market and revenue potential.
$455,000.00
Sep 1, 2025
For-profit organization
UK Multisector - BioM - EXPEDITE SAVeP: Expediting the self-amplifying nucleic acid vaccine preclinical process
1035592
The collaboration aims to streamline a self-amplifying nucleic acid vaccine validation and accelerate the progression from preclinical to clinical trials.